Abstract
Purpose
In this study, we determined serum 25-hydroxyvitamin D [25(OH) D] levels in serum, and investigated their associations with risk of recurrent stroke and mortality in a 24-month follow up study in Chinese patients with first-ever ischemic stroke.
Methods
In this preplanned post hoc analysis, serum levels of 25(OH) D and NIH stroke scale (NIHSS) were measured at the time of admission in a cohort of patients with ischemic stroke. We used logistic regression model to assess the relationship between 25(OH) D levels and risk recurrent stroke or mortality.
Results
The follow-up rate was 98.2% in 220 stroke patients. Of 216 patients, 18.5% (95%CI: 13.3%–23.7%) patients had a stroke recurrence, and 30.1% (95% CI: 24.0%–36.2%) died. After adjustment for traditional risk factors, serum 25(OH) D levels were negatively associated with the risk of stroke recurrence (odds ratio [OR], 0.77; 95% confidence interval [CI], 0.70–0.85; P< 0.001) and negatively associated with mortality during 24 months of follow-up (OR, 0.72; 95% CI, 0.64–0.80; P< 0.001). Compared with the first quartile of serum 25(OH) D levels, the ORs for stroke recurrence and mortality were as follows: second quartile, 0.80 (95% CI, 0.63–0.93) and 0.77 (95% CI, 0.65–0.89); third quartile, 0.42 (95% CI, 0.31–0.55) and 0.39 (95% CI, 0.30–0.52); fourth quartile, 0.12 (95% CI, 0.07–0.19) and 0.10 (95% CI, 0.06–0.15), respectively.
Conclusions
Lower serum levels of 25(OH) D are independently associated with the stroke recurrence and mortality at 24 months in ischemic stroke patients.
Similar content being viewed by others
References
Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, et al. Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China The Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke 2014; 45: 663–669.
Yin Y, Fan Y, Lin F, et al. Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: A cross-sectional study. The journal of nutrition, health & aging, 2015, 19(1): 39–47.
Pereira-Santos M, Costa P R F, Assis A M O, et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obesity reviews, 2015, 16(4): 341–349.
Littlejohns T J, Henley W E, Lang I A, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology, 2014, 83(10): 920–928.
Abbasi F, Feldman D, Caulfield M P, et al. Relationship among 25-hydroxyvitamin d concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension. American journal of hypertension, 2015, 28(2): 266–272.
Basile M, Ciardi L, Crespi I, et al. Assessing Serum Concentrations of 25-Hydroxy-Vitamin D in North-Western Italy. The Journal of frailty & aging; 2012, 2(4): 174–178.
Tu WJ, Zhao SJ, Xu DJ, Chen H. Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clinical Science 2014; 126: 339–346.
Rolland Y, de Souto Barreto P, Van Kan G A, et al. Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes. The journal of nutrition, health & aging, 2013, 17(4): 402–412.
Lee S, Teschemaker A R, Daniel M, et al. Calcium and vitamin D use among older adults in US: Results from national survey. The journal of nutrition, health & aging, 2016, 20(3): 300–305.
Kojima G, Bell C, Abbott R D, Launer L, Chen R, Motonaga H, et al. Low dietary vitamin D predicts 34-year incident stroke the Honolulu heart program. Stroke 2012; 43: 2163–2167.
Schneider AL, Lutsey PL, Selvin E, Mosley TH, Sharrett AR, Carson KA, et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. European Journal of Neurology 2015; 22: 1220–1227.
Brøndum-Jacobsen P, Nordestgaard B G, Schnohr P, Benn M. 25-Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta-Analysis. Annals of neurology 2013; 73: 38–47.
Park KY, Chung PW, Kim YB, Moon HS, Suh BC, Won YS, et al. Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke. Cerebrovasc Dis 2015; 40:73–80.
Daumas A, Daubail B, Legris N, et al. Association between Admission Serum 25-Hydroxyvitamin D Levels and Functional Outcome of Thrombolyzed Stroke Patients. Journal of Stroke and Cerebrovascular Diseases 2016; 25(4): 907–913.
Daubail B, Jacquin A, Guilland J C, Khoumri C, Aboa-Eboulé C, Giroud M, et al. Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovascular Diseases 2014; 37: 364–367.
Khoo S K, Tan J Y, Yeo L Y, et al. Vascular Events Occur More Frequently In Stroke Patients With Lower Concentrations of Vitamin D: A Prospective Cohort Analysis. Stroke, 2015, 46(Suppl 1): A151–A151.
Zhang Q, Ding H, Yan J, Wang W, Ma A, Zhu Z, et al. Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: a multicenter case–control study in China. Annals of neurology 2011; 70(2): 265–273.
Makariou SE, Michel P, Tzoufi MS, Challa A, Milionis HJ. Vitamin D and stroke: promise for prevention and better outcome. Current vascular pharmacology 2014; 12: 117–124.
Durup D, Jørgensen H L, Christensen J, et al. A Reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: The CopD Study. The Journal of Clinical Endocrinology & Metabolism 2015; 100(6): 2339–2346.
Huang H, Zheng T, Wang S, et al. Serum 25-hydroxyvitamin D predicts early recurrent stroke in ischemic stroke patients. Nutrition, Metabolism and Cardiovascular Diseases, 2016; DOI: http://dx.doi.org/10.1016/j.numecd.2016.06.009
Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 2013; 44: 1232–1237
Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology 2010; 74: 588–593.
Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5: 819–829.
Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes A meta-analysis of prospective studies. Diabetes care 2013; 36: 1422–1428.
Michos ED, Carson KA, Schneider AL, Lutsey PL, Xing L, Sharrett AR,et al. Vitamin D and subclinical cerebrovascular disease: the atherosclerosis risk in communities brain magnetic resonance imaging study. JAMA neurology 2014; 71: 863–871.
Chung PW, Park KY, Kim JM, Shin DW, Park MS, Chung YJ, et al. 25-hydroxyvitamin D status is associated with chronic cerebral small vessel disease. Stroke 2015; 46: 248–251.
Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH, et al. Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. American journal of epidemiology 2014; 179: 1279–1287.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qiu, H., Wang, M., Mi, D. et al. Vitamin D status and the risk of recurrent stroke and mortality in ischemic stroke patients: Data from a 24-month follow-up study in China. J Nutr Health Aging 21, 766–771 (2017). https://doi.org/10.1007/s12603-016-0821-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-016-0821-z